Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Advances in Therapy|May 31, 2022
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus ErythematosusAnca D Askanase, Richard A Furie
Expert Opinion on Pharmacotherapy|June 10, 2009
Abetimus sodium: a medication for the prevention of lupus nephritis flaresDiane M Horowitz, Richard A Furie
The Indian Journal of Chest Diseases & Allied Sciences|May 19, 2009
Pulmonary manifestations of primary Sjögren's syndromePralay K Sarkar, Nick Patel, Richard A Furie, et al.
Lupus Science & Medicine|January 19, 2018
Repository corticotropin injection in patients with persistently active SLE requiring corticosteroids: post hoc analysis of results from a two-part, 52-week pilot studyRichard A Furie, Margaret Mitrane, Enxu Zhao, et al.
Annals of the Rheumatic Diseases|January 23, 2023
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosusEric F Morand, Gabriel Abreu, Richard A Furie, et al.
Blood|January 20, 2011
β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse modelAriela Arad, Valerie Proulle, Richard A Furie, et al.
Rheumatology and Therapy|September 30, 2020
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Lupus Science & Medicine|May 14, 2020
Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trialAnca D Askanase, Enxu Zhao, Julie Zhu, et al.
Blood|May 15, 2014
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APSValerie Proulle, Richard A Furie, Glenn Merrill-Skoloff, et al.
Rheumatology and Therapy|September 3, 2021
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus ErythematosusAnca D Askanase, Dale Wright, Enxu Zhao, et al.
Pageof 7